Association Between TNF-α Promoter −308 A/G Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Case–Control Study and Meta-Analysis

Scandinavian Journal of Immunology

Volumn 85, Issue 3, 2017, Pages 197-210

  Yang, Z C ^a   Xu, F ^a   Tang, M ^a   Xiong, X ^a  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; ALLELE; ARTHRITIS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FEVER; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MOUTH ULCER; MYOSITIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROMOTER REGION; RASH; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; ADOLESCENT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 85015853103     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12516     Document Type: Article

References (60)

1. Alarcón-Segovia D, Alarcón-Riquelme ME, Cardiel MH et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005;52:1138–47.
2. Sabry A, Sheashaa H, El-Husseini A et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 2006;35:148–53.
3. Yokoyama H, Kreft B, Kelley VR. Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int 1995;47:122–30.
4. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195–9.
5. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 1997;17:631–5.
6. Karimi M, Goldie LC, Cruickshank MN, Moses EK, Abraham LJ. A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of -308 TNF polymorphism function using a novel integrated reporter system. Eur J Hum Genet 2009;17:1454–62.
7. Ahmed HH, Taha FM, Darweesh Hel S, Morsi HM. Association between TNF promoter -308 G>A and LTA 252 A>G polymorphisms and systemic lupus erythematosus. Mol Biol Rep 2014;41:2029–36.
8. Dourmishev L, Kamenarska Z, Hristova M, Dodova R, Kaneva R, Mitev V. Association of TNF-α polymorphisms with adult dermatomyositis and systemic lupus erythematosus in Bulgarian patients. Int J Dermatol 2012;51:1467–73.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
10. Churg J, Bernstein J, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Diseases, 2o edn. Churg JBJ, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Diseases. 2. New York, Tokyo: Igakuso Shoin; 1995.
11. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101–2.
12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58.
13. Tahghighi F, Ziaee V, Moradinejad MH et al. Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Hum Immunol 2015;76:533–6.
14. Piotrowski P, Wudarski M, Sowińska A, Olesińska M, Jagodziński PP. TNF-308 G/A polymorphism and risk of systemic lupus erythematosus in the Polish population. Mod Rheumatol 2015;25:719–23.
15. Muñoz SA, Aranda F, Allievi A et al. 4G/5G plasminogen activator inhibitor-1 and -308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis. Clin Exp Med 2014;14:83–9.
16. Angelo HD, da Silva HA, Asano NM, Muniz MT, de Mascena Diniz Maia M, de Souza PR. Tumor necrosis factor alpha promoter polymorphism -308 G/A in Brazilian patients with systemic lupus erythematosus. Hum Immunol 2012;73:1166–70.
17. Santos MJ, Carmona-Fernandes D, Caetano-Lopes J et al. TNF promoter -308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with systemic lupus erythematosus. Rheumatol Int 2012;32:2239–44.
18. Lin YJ, Wan L, Huang CM et al. IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 2010;28:318–24.
19. Rudwaleit M, Tikly M, Khamashta M et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996;23:1725–8.
20. Lin YJ, Chen RH, Wan L et al. Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 2009;18:974–9.
21. Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol 2009;70:251–6.
22. Tsai LJ, Hsiao SH, Tsai LM et al. The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE. Tissue Antigens 2008;71:114–26.
23. Hirankarn N, Avihingsanon Y, Wongpiyabovorn J. Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism -863, but not -308 and -238, in Thai population. Int J Immunogenet 2007;34:425–30.
24. Guarnizo-Zuccardi P, Lopez Y, Giraldo M et al. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 2007;70:376–82.
25. McHugh NJ, Owen P, Cox B, Dunphy J, Welsh K. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann Rheum Dis 2006;65:488–94.
26. Hrycek A, Siekiera U, Cieślik P, Szkróbka W. HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol Int 2005;26:1–6.
27. Suárez A, López P, Mozo L, Gutiérrez C. Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 2005;64:1605–10.
28. Schotte H, Willeke P, Tidow N et al. Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3. Scand J Rheumatol 2005;34:114–21.
29. Wang M, Huang S, Liu Y, Zhang J. Study on the association between tumor necrosis factor alpha and interleukin-6 gene polymorphisms and systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 1999;41:540–2.
30. Lu LY, Cheng HH, Sung PK, Tai MH, Yeh JJ, Chen A. Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan. J Formos Med Assoc 2005;104:563–70.
31. Parks CG, Pandey JP, Dooley MA et al. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol 2004;65:622–31.
32. Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac J Allergy Immunol 2004;22:159–63.
33. May LA, Huang Q, Morris D, Danis V, Manolios N. Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus. Lupus 2002;11:114–8.
34. Fu Z, Shen F, Jiang F, Ni P, Meng C. Study on the association between tumor necrosis factor-α gene polymorphism and systemic lupus erythematosus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:532–3.
35. van der Linden MW, van der Slik AR, Zanelli E et al. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun 2001;2:373–80.
36. Zúñiga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2001;2:363–6.
37. Liu Z, Tang K, Shi W, Xie H. Study of tumor necrosis factor-α gene polymorphism in patients with systemic lupus erythematosus. Zhonghua Pi Fu Ke Za Zhi 2001;34:56.
38. Rood MJ, van Krugten MV, Zanelli E et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000;43:129–34.
39. Wang M, Dong Y, Huang S. Study on the association between tumor necrosis factor alpha gene polymorphism and systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 1999;38:393–6.
40. Wang Y, Zhang Y, Zhu S. The association of susceptibility of SLE and the gene polymorphism of TNF. Zhonghua Yi Xue Za Zhi 1998;78:111–4.
41. Chen CJ, Yen JH, Tsai WC et al. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett 1997;55:1–3.
42. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997;40:2207–11.
43. D'Alfonso S, Colombo G, Della Bella S, Scorza R, Momigliano-Richiardi P. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 1996;47:551–5.
44. Fong KY, Howe HS, Tin SK, Boey ML, Feng PH. Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore 1996;25:90–3.
45. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 1995;12:127–33.
46. Wilson AG, Gordon C, di Giovine FS et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994;24:191–5.
47. Goldstein R, Sengar DP. Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum 1993;36:1121–7.
48. Fugger L, Morling N, Ryder LP et al. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 1989;34:17–22.
49. Pan HF, Leng RX, Ye DQ. Lack of association of interleukin-18 gene promoter -607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Lupus 2011;20:945–51.
50. López P, Gutiérrez C, Suárez A. IL-10 and TNFa genotypes in SLE. J Biomed Biotechnol 2010;2010:838390.
51. Joseph A, Brasington R, Kahl L, Ranganathan P, Cheng TP, Atkinson J. Immunologic rheumatic disorders. J Allergy Clin Immunol 2010;125:S204–15.
52. Leonardi CL, Powers JL, Matheson RT et al. Etanercept as monotherapy in patients with psoriasis. New Eng J Med 2003;349:2014–22.
53. Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999;53:527–33.
54. Morita C, Horiuchi T, Tsukamoto H et al. Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum 2001;44:2819–27.
55. Horiuchi T, Kiyohara C, Tsukamoto H et al. A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case–control study and a meta-analysis. Ann Rheum Dis 2007;66:320–4.
56. Mahmoud RA, El-Gendi HI, Ahmed HH. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Clin Biochem 2005;38:134–41.
57. Boechat AL, Boechat Nde O, Ogusku MM et al. The influence of a TNF gene polymorphism on the severity of rheumatoid arthritis in the Brazilian Amazon. Cytokine 2013;61:406–12.
58. Korolija M, Hadžija M, Medvidović EP et al. Genetic evaluation of the TNF-α -238G>A and -308G>A promoter polymorphisms in Croatian patients with type I diabetes. Hum Immunol 2012;71:1228–32.
59. Pan HF, Leng RX, Wang C et al. Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis. Rheumatol Int 2012;32:2083–92.
60. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508–10.